Rice Hall James & Associates, LLC Reata Pharmaceuticals Inc Transaction History

Rice Hall James & Associates, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$25.61 - $110.96 $2.94 Million - $12.7 Million	-114,806 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$100.0 - $143.02 $284,300 - $406,605	-2,843 Reduced 2.42%	114,806 $11.6 Million
Q2 2021 Jul 29, 2021	SELL	$78.27 - $151.29 $1.34 Million - $2.58 Million	-17,074 Reduced 12.67%	117,649 $16.7 Million
Q1 2021 May 14, 2021	SELL	$94.25 - $132.81 $104,146 - $146,755	-1,105 Reduced 0.81%	134,723 $13.4 Million
Q4 2020 Feb 16, 2021	SELL	$102.03 - $184.62 $3.82 Million - $6.92 Million	-37,464 Reduced 21.62%	135,828 $16.8 Million

Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $4.27 Million - $7.46 Million	45,654 Added 35.77%	173,292 $16.9 Million
Q2 2020 Aug 14, 2020	BUY	$126.3 - $176.56 $3.37 Million - $4.72 Million	26,712 Added 26.47%	127,638 $19.9 Million
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $424,999 - $848,014	-3,423 Reduced 3.28%	100,926 $14.6 Million
Q4 2019 Jan 29, 2020	SELL	$74.57 - $217.92 $195,298 - $570,732	-2,619 Reduced 2.45%	104,349 $21.3 Million
Q3 2019 Oct 30, 2019	SELL	$71.26 - $95.75 $154,135 - $207,107	-2,163 Reduced 1.98%	106,968 $8.59 Million
Q2 2019 Aug 01, 2019	SELL	$77.72 - $94.35 $527,485 - $640,353	-6,787 Reduced 5.86%	109,131 $10.3 Million
Q1 2019 May 01, 2019	BUY	$51.9 - $101.79 $6.02 Million - $11.8 Million	115,918 New	115,918 $9.91 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.